Pancreatic Cancer Research

ResearcherYamagata UniversityActive in the last 2 years

Takashi Yoshioka

Matched on ORCID iD 0000-0001-7709-8278; OpenAlex author ID A5023481395. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2011: 4 papers · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 10

  1. Quality-of-life survey of pancreatic cancer patients: a comparison between general public and physicians. Co-author DOI 10.3389/frhs.2024.1275496↗
  2. Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13667↗
  3. Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine. Co-author DOI 10.21873/anticanres.11227↗
  4. JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells. Co-author DOI 10.18632/oncotarget.2693↗
  5. Personalization of chemotherapy for metastatic pancreatic cancer. Last author DOI 10.4137/ccrep.s14478↗
  6. UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells. Co-author DOI 10.3892/or.2011.1612↗
  7. Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5' AMP-activated protein kinase. Co-author DOI 10.1016/j.bbrc.2011.09.020↗
  8. Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2011.09.008↗
  9. Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells. Co-author DOI 10.1186/1476-4598-10-79↗
  10. UVC radiation induces downregulation of EGF receptor via phosphorylation at serine 1046/1047 in human pancreatic cancer cells. Co-author DOI 10.1667/rr2445.1↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroyuki Takeda · 3 shared papers, 2015–2024 · strength 0.30
  2. Yuriko Sasahara · 2 shared papers, 2014–2024 · strength 0.24
  3. Chifumi Kitanaka · 3 shared papers, 2015–2019 · strength 0.21
  4. Shuhei Suzuki · 3 shared papers, 2015–2019 · strength 0.21
  5. Kumiko Umemoto · 1 shared paper, 2024 · strength 0.19
  6. Yuki Takumoto · 1 shared paper, 2024 · strength 0.19
  7. Hiroto Narimatsu · 1 shared paper, 2024 · strength 0.19
  8. Manabu Akazawa · 1 shared paper, 2024 · strength 0.19
  9. Makoto Ueno · 1 shared paper, 2024 · strength 0.19
  10. Yu Sunakawa · 1 shared paper, 2024 · strength 0.19
  11. Tomomi Sanomachi · 2 shared papers, 2016–2019 · strength 0.16
  12. Junji Kawaguchi · 5 shared papers, 2011–2012 · strength 0.13
  13. Seiji Adachi · 5 shared papers, 2011–2012 · strength 0.13
  14. Osamu Kozawa · 5 shared papers, 2011–2012 · strength 0.13
  15. Ichiro Yasuda · 5 shared papers, 2011–2012 · strength 0.13
  16. Takahiro Yamauchi · 5 shared papers, 2011–2012 · strength 0.13
  17. Hisataka Moriwaki · 5 shared papers, 2011–2012 · strength 0.13
  18. Masahiro Yamamoto · 1 shared paper, 2019 · strength 0.10
  19. Masanori Nakashima · 4 shared papers, 2011 · strength 0.10
  20. Atsushi Satō · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.